(3-{2-[(4-Fluorophenyl)sulfonyl]-5-methoxybenzyl}-2-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indol-1-yl)acetic acid

ID: ALA3774415

Chembl Id: CHEMBL3774415

PubChem CID: 127033547

Max Phase: Preclinical

Molecular Formula: C25H24FNO6S

Molecular Weight: 485.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)c2ccc(F)cc2)c(Cc2c3c(n(CC(=O)O)c2C)CCCC3=O)c1

Standard InChI:  InChI=1S/C25H24FNO6S/c1-15-20(25-21(4-3-5-22(25)28)27(15)14-24(29)30)13-16-12-18(33-2)8-11-23(16)34(31,32)19-9-6-17(26)7-10-19/h6-12H,3-5,13-14H2,1-2H3,(H,29,30)

Standard InChI Key:  VWSAIXQGXMYPHJ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3774415

    ---

Associated Targets(Human)

PEX16 Tbio Peroxisomal membrane protein PEX16 (26 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGDR2 Tchem G protein-coupled receptor 44 (4688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.53Molecular Weight (Monoisotopic): 485.1308AlogP: 3.97#Rotatable Bonds: 7
Polar Surface Area: 102.67Molecular Species: ACIDHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.13CX Basic pKa: CX LogP: 4.06CX LogD: 0.60
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.51Np Likeness Score: -0.99

References

1. Buil MA, Calbet M, Castillo M, Castro J, Esteve C, Ferrer M, Forns P, González J, López S, Roberts RS, Sevilla S, Vidal B, Vidal L, Vilaseca P..  (2016)  Structure-activity relationships (SAR) and structure-kinetic relationships (SKR) of sulphone-based CRTh2 antagonists.,  113  [PMID:26922232] [10.1016/j.ejmech.2016.02.023]

Source